The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
The conclave brought together over 1,000 delegates from across India and internationally
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
Move to accelerate cancer care expansion across India
PMDA is regarded among the most stringent regulatory bodies globally
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
The innovation is particularly suited for bone and cartilage repair
Subscribe To Our Newsletter & Stay Updated
